ArticleThe Lancet. Oncology2022

Use of a Cytosponge biomarker panel to prioritise endoscopic Barrett's oesophagus surveillance: a cross-sectional study followed by a real-world prospective pilot.

Nastazja Dagny Pilonis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.